How I treat priapism

Uzoma A. Anele, Brian V. Le, Linda M Smith Resar, Arthur Burnett

Research output: Contribution to journalArticle

Abstract

Priapism is a disorder of persistent penile erection unrelated to sexual interest or desire. This pathologic condition, specifically the ischemic variant, is often associated with devastating complications, notably erectile dysfunction. Because priapism demonstrates high prevalence in patients with hematologic disorders, most commonly sickle cell disease (SCD), there is significant concern for its sequelae in this affected population. Thus, timely diagnosis and management are critical for the prevention or at least reduction of cavernosal tissue ischemia and potential damage consequent to each episode. Current guidelines and management strategies focus primarily on reactive treatments. However, an increasing understanding of the molecular pathophysiology of SCD-associated priapism has led to the identification of new potential therapeutic targets. Future agents are being developed and explored for use in the prevention of priapism.

Original languageEnglish (US)
Pages (from-to)3551-3558
Number of pages8
JournalBlood
Volume125
Issue number23
DOIs
StatePublished - Jun 4 2015

Fingerprint

Priapism
Sickle Cell Anemia
Tissue
Penile Erection
Erectile Dysfunction
Ischemia
Guidelines
Therapeutics
Population

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

How I treat priapism. / Anele, Uzoma A.; Le, Brian V.; Smith Resar, Linda M; Burnett, Arthur.

In: Blood, Vol. 125, No. 23, 04.06.2015, p. 3551-3558.

Research output: Contribution to journalArticle

Anele, Uzoma A. ; Le, Brian V. ; Smith Resar, Linda M ; Burnett, Arthur. / How I treat priapism. In: Blood. 2015 ; Vol. 125, No. 23. pp. 3551-3558.
@article{c64d55615ed343ed9564701b428847b9,
title = "How I treat priapism",
abstract = "Priapism is a disorder of persistent penile erection unrelated to sexual interest or desire. This pathologic condition, specifically the ischemic variant, is often associated with devastating complications, notably erectile dysfunction. Because priapism demonstrates high prevalence in patients with hematologic disorders, most commonly sickle cell disease (SCD), there is significant concern for its sequelae in this affected population. Thus, timely diagnosis and management are critical for the prevention or at least reduction of cavernosal tissue ischemia and potential damage consequent to each episode. Current guidelines and management strategies focus primarily on reactive treatments. However, an increasing understanding of the molecular pathophysiology of SCD-associated priapism has led to the identification of new potential therapeutic targets. Future agents are being developed and explored for use in the prevention of priapism.",
author = "Anele, {Uzoma A.} and Le, {Brian V.} and {Smith Resar}, {Linda M} and Arthur Burnett",
year = "2015",
month = "6",
day = "4",
doi = "10.1182/blood-2014-09-551887",
language = "English (US)",
volume = "125",
pages = "3551--3558",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "23",

}

TY - JOUR

T1 - How I treat priapism

AU - Anele, Uzoma A.

AU - Le, Brian V.

AU - Smith Resar, Linda M

AU - Burnett, Arthur

PY - 2015/6/4

Y1 - 2015/6/4

N2 - Priapism is a disorder of persistent penile erection unrelated to sexual interest or desire. This pathologic condition, specifically the ischemic variant, is often associated with devastating complications, notably erectile dysfunction. Because priapism demonstrates high prevalence in patients with hematologic disorders, most commonly sickle cell disease (SCD), there is significant concern for its sequelae in this affected population. Thus, timely diagnosis and management are critical for the prevention or at least reduction of cavernosal tissue ischemia and potential damage consequent to each episode. Current guidelines and management strategies focus primarily on reactive treatments. However, an increasing understanding of the molecular pathophysiology of SCD-associated priapism has led to the identification of new potential therapeutic targets. Future agents are being developed and explored for use in the prevention of priapism.

AB - Priapism is a disorder of persistent penile erection unrelated to sexual interest or desire. This pathologic condition, specifically the ischemic variant, is often associated with devastating complications, notably erectile dysfunction. Because priapism demonstrates high prevalence in patients with hematologic disorders, most commonly sickle cell disease (SCD), there is significant concern for its sequelae in this affected population. Thus, timely diagnosis and management are critical for the prevention or at least reduction of cavernosal tissue ischemia and potential damage consequent to each episode. Current guidelines and management strategies focus primarily on reactive treatments. However, an increasing understanding of the molecular pathophysiology of SCD-associated priapism has led to the identification of new potential therapeutic targets. Future agents are being developed and explored for use in the prevention of priapism.

UR - http://www.scopus.com/inward/record.url?scp=84930958693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930958693&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-09-551887

DO - 10.1182/blood-2014-09-551887

M3 - Article

VL - 125

SP - 3551

EP - 3558

JO - Blood

JF - Blood

SN - 0006-4971

IS - 23

ER -